DHG Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
904,484.00
1,159,174.00
1,099,613.00
864,751.00
821,023.00
713,195.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
478,383.00
-703,204.00
-43,045.00
-294,579.00
114,133.00
198,176.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,474,369.00
420,040.00
1,020,007.00
554,821.00
958,965.00
964,088.00
Cash Flow from Investing Activities
-602,736.00
-359,688.00
-472,451.00
-58,090.00
-380,883.00
-349,504.00
Cash Flow from Financing Activities
-902,846.00
-170.00
-550,279.00
-527,864.00
-575,379.00
-620,099.00
Net Cash Inflow / Outflow
-31,276.00
60,116.00
-2,945.00
-31,088.00
2,726.00
-5,507.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-62.00
-65.00
-222.00
45.00
23.00
7.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DHG Pharmaceutical JSC
Figures in Million
consolidated Cash Flow Results
Change(VND)
Change(%)
Profit Before Tax
904484.566816
404192.934555
5,00,292.00
123.78%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
478383.501874
-215510.869052
6,93,893.00
321.98%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1474369.198406
223942.752993
12,50,427.00
558.37%
Cash Flow from Investing Activities
-602736.987502
-134874.380432
-4,67,862.00
-346.89%
Cash Flow from Financing Activities
-902846.163646
-33304.800015
-8,69,542.00
-2610.86%
Net Cash Inflow / Outflow
-31276.478746
55782.749596
-87,058.00
-156.07%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-62.526004
19.17705
-81.00
-426.05%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 251.01% vs -58.82% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
14,74,369.20
4,20,040.41
251.01%






